A Study to Validate the Relevance of Semen F 2 -Isoprostanes on Human Male Infertility.
Moretti ElenaCinzia SignoriniFabio FerrettiDaria NotoCollodel GiuliaPublished in: International journal of environmental research and public health (2022)
F 2 -isoprostanes (F 2 -IsoPs), byproducts of arachidonic acid oxidation, are one of the most reliable indices for assessing lipid peroxidation in vivo. This study aimed at evaluating the seminal F 2 -IsoP level in 147 patients with different reproductive conditions (varicocele, urogenital infection, idiopathic infertility) and 45 fertile controls to establish a cut-off value discriminating physiological and pathological ranges. Semen analyses were performed following WHO guidelines; F 2 -IsoP levels were measured by gas chromatography/negative-ion chemical ionization tandem mass spectrometry. Considering the whole group of patients, F 2 -IsoPs correlated negatively with normal morphology (r = -0.283, p < 0.01), viability (r = -0.245, p < 0.01), total progressive motility (r = -0.309, p < 0.01) and rapid motility (r = -0.535, p < 0.01). The area under the ROC curve for F 2 -IsoP levels was 0.839, indicating a good performance of the test; the Youden index showed a cut-off value of 29.96 ng/mL. Fertile men (except one) were distributed in the group of patients with F 2 -IsoP level < 29.96 ng/mL. Varicocele and urogenital infection groups showed the highest levels of F 2 -IsoPs in semen. For the first time, a cut-off for F 2 -IsoPs is identified in human semen. It allows discriminating different male infertility conditions by the semen F 2 -IsoP amounts, as an additional parameter for clinical evaluation.
Keyphrases
- gas chromatography
- tandem mass spectrometry
- ultra high performance liquid chromatography
- mass spectrometry
- high performance liquid chromatography
- endothelial cells
- liquid chromatography
- high resolution mass spectrometry
- clinical evaluation
- simultaneous determination
- end stage renal disease
- gas chromatography mass spectrometry
- solid phase extraction
- induced pluripotent stem cells
- multiple sclerosis
- high resolution
- chronic kidney disease
- polycystic ovary syndrome
- newly diagnosed
- prognostic factors
- ejection fraction
- biofilm formation
- pluripotent stem cells
- drinking water
- patient reported outcomes
- staphylococcus aureus
- metabolic syndrome
- type diabetes
- peritoneal dialysis
- insulin resistance
- adipose tissue
- fatty acid
- candida albicans
- nitric oxide